European Commission Steps Further Towards ‘Ambitious’ Pharma Legislation Reform
Executive Summary
The incentives system, access to medicines, future proofing for novel products and antimicrobial resistance are just some of the topics included in a new consultation.
You may also be interested in...
EU Committee Backs Collective Drug Price Talks, Early-Warning System For Shortages
A report beefing up the proposals contained in the European Commission’s Pharmaceutical Strategy has been approved by an influential parliamentary committee that wants to see a “stable, updated and safety-centered regulatory system” and an "autonomous and resilient" pharmaceutical industry.
Future Proofing & Incentives Among Industry Priorities In EU Pharma Law Shake UP
Overhaul of the pharmaceutical legislation in the EU is an opportunity to learn from COVID-19, says European industry body.
EU Launches New Response Body To Tackle Future Health Emergencies
The European Commission has dismissed concerns about the operation of its new emergency response body, saying it will ensure the EU is well prepared for tackling future pandemics and other threats. HERA will complement, not duplicate, work conducted by existing agencies such as the European Medicines Agency, delegates heard at this week’s European Health Forum Gastein virtual conference.